Recruiting Studies
Advanced SearchData: ClinicalTrials.gov · Source of record for eligibility and locations
Top Cities for Pulmonary Hypertension Clinical Trials
Pulmonary Hypertension clinical trials are recruiting across 200 cities. Here are the cities with the most active studies:
Pulmonary Hypertension Trial Phases
76 research organizations are sponsoring pulmonary hypertension trials.
About Pulmonary Hypertension
Pulmonary hypertension is a type of high blood pressure that affects the arteries in the lungs and the right side of the heart. It can lead to heart failure if untreated. Treatment includes vasodilators, endothelin receptor antagonists, and PDE-5 inhibitors.
Clinical trials are advancing new treatments for pulmonary hypertension. Currently, 100 studies are recruiting a combined 585,965 participants across the United States. Research is being conducted by 76 organizations including ClinLogic LLC, CDx Diagnostics, Centers for Disease Control and Prevention and 73 others.
2026 Pulmonary Hypertension Research Landscape
As of July 2026, the pulmonary hypertension clinical trial landscape includes 100 actively recruiting studies across 200 cities in the United States. These studies are collectively seeking 585,965 participants, with an average enrollment target of 5,860 per study.
The research spans multiple phases of development: 24 studies are in PHASE3, 12 studies are in NA, 4 studies are in PHASE2, 2 studies are in PHASE1, 2 studies are in PHASE4. The presence of Phase 3 trials indicates that some pulmonary hypertension treatments are in late-stage testing and may be approaching regulatory review.
Research is being led by 76 different organizations, including ClinLogic LLC, CDx Diagnostics, Centers for Disease Control and Prevention, Rutgers, The State University of New Jersey, The Duchenne Registry, and 71 others. The large number of sponsors reflects significant research interest and investment in pulmonary hypertension treatment advancement.
Geographically, pulmonary hypertension trials are most concentrated in Aurora, Colorado (15 trials); Los Angeles, California (14 trials); Birmingham, Alabama (13 trials); Phoenix, Arizona (13 trials); New York, New York (13 trials) and 7 other cities.
Featured Pulmonary Hypertension Studies
Highlighted recruiting studies for pulmonary hypertension, selected by enrollment size and research scope.
Reduction of Adverse Drug Events and Readmissions
Pharmocogenomic test assessment in the medication regimen and disease management for patients under drugs known with genetic variation.
Clinical Utility of WATS3D: A 5-Year Prospective Study
The purpose of this study is to create a registry (collect data and keep it in a research database) to learn more about two methods of taking small tissue samples from your esophagus (the esophagus is the tube that carries food and liquid from your mouth to your stomach). The two methods of sampling are: 1) Using forceps that take biopsies (small tissue samples) from your esophagus, and 2) Using a...
The National Amyotrophic Lateral Sclerosis Registry
The purpose of this registry is to (A) better describe the incidence and prevalence of Amyotrophic Lateral Sclerosis (ALS) in the United States;(B) examine appropriate factors, such as environmental and occupational, that may be associated with the disease; (C) better outline key demographic factors (such as age, race or ethnicity, gender, and family history of individuals who are diagnosed with t...
Frequently Asked Questions About Pulmonary Hypertension Clinical Trials
Are there pulmonary hypertension clinical trials near me?
Yes, there are 100 pulmonary hypertension clinical trials currently recruiting across 200+ cities in the United States, including Aurora, Colorado; Los Angeles, California; Birmingham, Alabama. Browse the studies above to find one at a location convenient for you.
How do I join a pulmonary hypertension clinical trial?
To join a pulmonary hypertension clinical trial: 1) Browse the available studies on this page, 2) Click on a study that interests you, 3) Check the study locations to find a site near you, 4) Review the eligibility criteria, and 5) Contact the study site or complete the eligibility form. The process is free and you can withdraw at any time.
Are pulmonary hypertension clinical trials free?
Yes, participation in pulmonary hypertension clinical trials is free. Study-related treatments, medical tests, and doctor visits are provided at no cost to participants. Many studies also offer compensation for your time and travel expenses.
What types of pulmonary hypertension treatments are being studied?
Current pulmonary hypertension clinical trials are testing a range of approaches across PHASE3 (24 studies), NA (12 studies), PHASE2 (4 studies), PHASE1 (2 studies), PHASE4 (2 studies). These include new drugs, combination therapies, medical devices, and other interventions sponsored by 76 research organizations.
Is it safe to participate in pulmonary hypertension clinical trials?
Clinical trials are carefully regulated by the FDA and institutional review boards (IRBs). All trials must follow strict safety protocols, and participants receive close medical monitoring throughout the study. You can withdraw from a trial at any time without penalty.
Data updated July 16, 2026 from ClinicalTrials.gov
About This Data
Data: ClinicalTrials.gov · Source of record for eligibility and locations
Clinical trial information on this page is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health (NIH) and National Library of Medicine (NLM). Study data is refreshed every hour to ensure accuracy.
Medical Disclaimer: The information provided on this page is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before making decisions about clinical trial participation or changes to your treatment plan.
Page reviewed by the HelloStudys Research Team · Last updated July 16, 2026 · Data from ClinicalTrials.gov